Literature DB >> 12482659

Interaction of human papillomavirus type 16 L2 with cellular proteins: identification of novel nuclear body-associated proteins.

Janina Görnemann1, Thomas G Hofmann, Hans Will, Martin Müller.   

Abstract

Two structural proteins form the Papillomavirus (PV) capsids. While the functions of the major structural protein L1 are well established, the exact functions for the minor structural protein L2 are much less well defined, except for some information on a role in viral entry and maturation of infectious virions. To gain more insight in the function of L2 we used the yeast two hybrid system with the Human Papillomavirus (HPV) 11 L2 and HPV16 L2 as bait proteins to isolate putative cellular interaction partners. We identified four proteins interacting with L2 proteins of at least two different HPV types and this interaction was confirmed in vitro by pull-down assays. Further evidence for this interaction was obtained by in vivo localization studies. Two of the proteins, the previously described PATZ and a novel protein, designated PLINP, were localized in discrete nuclear domains and colocalized with L2. The third protein, designated PMSP, is a newly identified cytoplasmic protein which was recruited to nuclear dots when coexpressed with L2. The fourth protein interacting with HPV16, 11 and 1 L2, the tubular-nephritis antigen related protein (TIN-Ag-RP), shows a cytoplasmic as well as a membrane bound subcellular distribution. Taken together, our data indicate that L2 of HPVs with different phenotypes interacts with several cellular host proteins, recruits one of them to the nucleus, and is complexed with at least three cellular proteins in specific nuclear domains. These findings suggest an HPV type-independent modulatory function of L2 on host-cell functions that involves discrete nuclear domains and alteration of the subcellular distribution of cellular proteins. The interacting cellular proteins identified may play a role in the viral life cycle and establishment of viral persistence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12482659     DOI: 10.1006/viro.2002.1670

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  Study of infectious virus production from HPV18/16 capsid chimeras.

Authors:  Horng-Shen Chen; Jennifer Bromberg-White; Michael J Conway; Samina Alam; Craig Meyers
Journal:  Virology       Date:  2010-07-03       Impact factor: 3.616

2.  The high risk HPV16 L2 minor capsid protein has multiple transport signals that mediate its nucleocytoplasmic traffic.

Authors:  Shahan Mamoor; Zeynep Onder; Balasubramanyam Karanam; Kihyuck Kwak; Jennifer Bordeaux; Lauren Crosby; Richard B S Roden; Junona Moroianu
Journal:  Virology       Date:  2011-12-06       Impact factor: 3.616

3.  The transcription factors TBX2 and TBX3 interact with human papillomavirus 16 (HPV16) L2 and repress the long control region of HPVs.

Authors:  Marc A Schneider; Konstanze D Scheffer; Timo Bund; Fatima Boukhallouk; Carsten Lambert; Cristina Cotarelo; Gert O Pflugfelder; Luise Florin; Gilles A Spoden
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

4.  Crif1 is a novel transcriptional coactivator of STAT3.

Authors:  Min-chul Kwon; Bon-Kyoung Koo; Jin-Sook Moon; Yoon-Young Kim; Ki Cheol Park; Nam-Shik Kim; Mi Yi Kwon; Myung-Phil Kong; Ki-Jun Yoon; Sun-Kyoung Im; Jaewang Ghim; Yong-Mahn Han; Sung Key Jang; Minho Shong; Young-Yun Kong
Journal:  EMBO J       Date:  2008-01-17       Impact factor: 11.598

5.  Nuclear localization but not PML protein is required for incorporation of the papillomavirus minor capsid protein L2 into virus-like particles.

Authors:  Katrin A Becker; Luise Florin; Cornelia Sapp; Gerd G Maul; Martin Sapp
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

6.  Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2.

Authors:  Zhenhua Lin; Anna V Yemelyanova; Ratish Gambhira; Subhashini Jagu; Craig Meyers; Reinhard Kirnbauer; Brigitte M Ronnett; Patti E Gravitt; Richard B S Roden
Journal:  Am J Pathol       Date:  2008-12-18       Impact factor: 4.307

Review 7.  L2, the minor capsid protein of papillomavirus.

Authors:  Joshua W Wang; Richard B S Roden
Journal:  Virology       Date:  2013-05-17       Impact factor: 3.616

8.  Essential role of CR6-interacting factor 1 (Crif1) in E74-like factor 3 (ELF3)-mediated intestinal development.

Authors:  Min-Chul Kwon; Bon-Kyoung Koo; Yoon-Young Kim; Sang-Hee Lee; Nam-Shik Kim; Jae-Hwan Kim; Young-Yun Kong
Journal:  J Biol Chem       Date:  2009-09-28       Impact factor: 5.157

Review 9.  Host-cell factors involved in papillomavirus entry.

Authors:  Luise Florin; Martin Sapp; Gilles A Spoden
Journal:  Med Microbiol Immunol       Date:  2012-09-13       Impact factor: 4.148

10.  Differential expression of HPV16 L2 gene in cervical cancers harboring episomal HPV16 genomes: influence of synonymous and non-coding region variations.

Authors:  Paramita Mandal; Bornali Bhattacharjee; Damayanti Das Ghosh; Nidhu Ranjan Mondal; Rahul Roy Chowdhury; Sudipta Roy; Sharmila Sengupta
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.